0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

JAMA Oncology | 
Brief Report |  ONLINE FIRST
Mark A. Dickson, MD; Gary K. Schwartz, MD; Mary Louise Keohan, MD; et al.
JAMA Oncol. Published online April 28, 2016. doi:10.1001/jamaoncol.2016.0264
Includes: Supplemental Content

JAMA Oncology | 
Research Letter |  ONLINE FIRST
Stacie B. Dusetzina, PhD
JAMA Oncol. Published online April 28, 2016. doi:10.1001/jamaoncol.2016.0648

JAMA Oncology | 
Original Investigation |  ONLINE FIRST
Julien Péron, MD, PhD; Pascal Roy, MD, PhD; Brice Ozenne, PhD; et al.
JAMA Oncol. Published online April 28, 2016. doi:10.1001/jamaoncol.2015.6359
Includes: Supplemental Content

JAMA Oncology | 
Original Investigation |  ONLINE FIRST
Guo Chen, PhD; Jennifer L. McQuade, MD; David J. Panka, PhD; et al.
JAMA Oncol. Published online April 28, 2016. doi:10.1001/jamaoncol.2016.0509
Includes: Supplemental Content

JAMA Dermatology | 
Research Letter |  ONLINE FIRST
Drew J. B. Kurtzman, MD; Natalie A. Wright, MD; Janice Lin, MD; et al.
JAMA Dermatol. Published online April 27, 2016. doi:10.1001/jamadermatol.2016.0866

JAMA Oncology | 
Invited Commentary |  ONLINE FIRST
Anne F. Schott, MD
JAMA Oncol. Published online April 21, 2016. doi:10.1001/jamaoncol.2016.0446

JAMA Oncology | 
Research Letter |  ONLINE FIRST
Kathleen Van Dyk, PhD; Laura Petersen, MS; Patricia A. Ganz, MD
JAMA Oncol. Published online April 21, 2016. doi:10.1001/jamaoncol.2016.0350

JAMA Oncology | 
Original Investigation |  ONLINE FIRST
Sherene Loi, MD, PhD; Urania Dafni, ScD; Dimitris Karlis, PhD; et al.
JAMA Oncol. Published online April 21, 2016. doi:10.1001/jamaoncol.2016.0339
Includes: Supplemental Content

JAMA Oncology | 
Original Investigation |  ONLINE FIRST
Reina Haque, PhD; Jiaxiao Shi, PhD; Joanne E. Schottinger, MD; et al.
JAMA Oncol. Published online April 21, 2016. doi:10.1001/jamaoncol.2016.0429
Includes: Supplemental Content

JAMA Oncology | 
Review |  ONLINE FIRST
Kevin Wood, MD; Thomas Hensing, MD; Raeva Malik, MD; et al.
JAMA Oncol. Published online April 21, 2016. doi:10.1001/jamaoncol.2016.0405
Includes: Supplemental Content

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Brief Report  | 
Progression-Free Survival Among Patients With Well-Differentiated or Dedifferentiated Liposarcoma Treated With CDK4 Inhibitor Palbociclib A Phase 2 Clinical Trial
Mark A. Dickson, MD; Gary K. Schwartz, MD; Mary Louise Keohan, MD; et al.
JAMA Oncology
Research Letter  | 
Drug Pricing Trends for Orally Administered Anticancer Medications Reimbursed by Commercial Health Plans, 2000-2014
Stacie B. Dusetzina, PhD
JAMA Oncology
Original Investigation  | 
The Net Chance of a Longer Survival as a Patient-Oriented Measure of Treatment Benefit in Randomized Clinical Trials
Julien Péron, MD, PhD; Pascal Roy, MD, PhD; Brice Ozenne, PhD; et al.
JAMA Oncology
Original Investigation  | 
Clinical, Molecular, and Immune Analysis of Dabrafenib-Trametinib Combination Treatment for BRAF Inhibitor–Refractory Metastatic Melanoma A Phase 2 Clinical Trial
Guo Chen, PhD; Jennifer L. McQuade, MD; David J. Panka, PhD; et al.